All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

AbbVie, Trump Reach Drug Pricing Deal That Could Cut Costs for Older Americans

By

[email protected] ( Washington Bureau)

5mo agoen

Source

ltcnews.comAbbVie, Trump Reach Drug Pricing Deal That Could Cut Costs for Older Americansltcnews.com
Snippet from the RSS feed
Breaking news: New deal between AbbVie and the Trump administration could reshape drug costs, tariffs, and how seniors buy medications in 2026.

You might also wanna read

Drugmakers Plan Price Increases on 350+ Medications Despite Government Pressure

Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including COVID, RSV, and shingles vaccines, as well as ca

reuters.com·6mo ago

White House Launches TrumpRx Direct-to-Consumer Drug Pricing Website

The White House has launched TrumpRx, a direct-to-consumer drug pricing website that allows patients to purchase certain medications at disc

cnbc.com·5mo ago

ACA enrollees face massive premium hikes and coverage downgrades as enhanced tax credits expire under Trump/GOP policies

This article analyzes how ACA (Affordable Care Act) health insurance enrollees are facing massive premium increases in 2026 due to the expir

acasignups.net·1d ago

STAT+: Medicare takes another swing at 340B cuts to hospitals

STAT·5d ago

Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn

Analysis claims the US-UK trade deal agreed in December will force the NHS to divert billions from essential services to pay for new medicin

theguardian.com·4d ago

Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o

bmj.com·5d ago

Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o

bmj.com·5d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.